CF45776-61A - 0x00000000000069D7
Males & Females of Non-Childbearing Potential
Nutshell
* Stipend may pay up to reflected amount.
Start Date:
January 22, 2026 - 3:15pm
End Date:
February 19, 2026 - 12:45pm
Study Details
Study Number: CF45776
Group Number: 61A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $11,500.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 30
Study Schedule
Schedule Type: Long Term
Study Length: One -15 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date |
|---|---|
| Friday | 1/2/2026 |
| Friday | 1/2/2026 |
| Tuesday | 1/6/2026 |
| Tuesday | 1/6/2026 |
| Wednesday | 1/7/2026 |
| Wednesday | 1/7/2026 |
| Thursday | 1/8/2026 |
| Thursday | 1/8/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 1/8/2026 |
| Thursday | 1/8/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Thursday | 1/22/2026 3:15:00 PM | Friday | 2/6/2026 7:15:00 PM | 1 | Lincoln |
| Check-In | Thursday | 1/22/2026 3:15:00 PM | Friday | 2/6/2026 7:15:00 PM | 1 | Lincoln |
| Phone participant | Thursday | 2/19/2026 12:45:00 PM | 1 | Lincoln | ||
| Phone participant | Thursday | 2/19/2026 12:45:00 PM | 1 | Lincoln |
